HEXCEED
Live / Registered — Registered — partial invalidation of extension of protection (as of 25 Aug 2026)
What this means for you
Registered since 19 May 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 May 2030: the §71 ten-year affidavit of use).
Record
- Serial number
- 79265244
- Registration number
- 6055660
- Mark type
- Word mark
- Filed
- 14 May 2019
- Published for opposition
- 03 Mar 2020
- Registered
- 19 May 2020
- Next maintenance filing
- §71 ten-year affidavit of use, due by 19 May 2030 (grace period to 19 Nov 2030)
- Attorney of record
- Max Vern
Goods and services
- Class 001 — Chemicals: [ Chemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals ]
- Class 005 — Pharmaceuticals: [ Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as antibody fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases ]
- Class 042 — Scientific and technological services: Medical scientific and biological research, namely research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these [ ; chemical analysis; computer programming, namely programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these ]
- Class 045 — Legal and security services: [ Legal services in the field of patent exploitation; licensing of intellectual property in the field of medicine ]
Owner
- Genmab B.V., Utrecht, NL
- Genmab B.V., NL
- Genmab B.V., NL
Prosecution history
- 25 Aug 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 25 Aug 2026 — REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
- 24 Aug 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Jul 2026 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 28 Jul 2026 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 29 May 2026 — TEAS SECTION 71 & 15 RECEIVED
- 14 May 2026 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 05 Mar 2026 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 19 May 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 24 Apr 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 05 Jun 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 05 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Jun 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED